[Editorial] Stem cell dollars flow; But grant process is needlessly shrouded
By Sacramento Bee,
Sacramento Bee
| 02. 12. 2007
California's stem cell research institute has received little attention of late, and agency officials probably prefer it that way. But while the media have been off covering sex scandals involving mayors and astronauts, the Institute for Regenerative Medicine has been quietly preparing, for the first time in its two-year history, to dispense millions of public dollars for embryonic stem cell research.
This week, on Thursday and Friday, the institute's oversight committee will meet in San Francisco to decide on roughly $24 million in grants for new stem cell researchers with innovative ideas. While that may be pocket change compared with the $3 billion that voters authorized when they endorsed Proposition 71 in 2004, this initial research funding is historic, and other grants totaling about $100 million will soon follow this year.
Taxpayers curious about how their money will be spent can go to the institute's Web site -- www.cirm.ca.gov/publicsummaries/PublicList.html -- to see the 30 scientific proposals recommended for funding. The site also includes 200 other projects that didn't make the cut, with summaries and scientific assessments -- some of them...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...